Cargando…
Combination treatment of dupilumab with bortezomib in a patient with IgG kappa gammopathy of renal significance, uremic pruritus and chronic lichenoid dermatitis
Chronic pruritus (CP) is one of the most frequent symptoms among dermatological conditions, capable of reducing the quality of life (QoL). CP may be induced by atopic dermatitis or other dermatological and/or non-dermatological conditions. In this article, we report the case of a patient affected by...
Autores principales: | Paolino, Giovanni, Di Nicola, Matteo Riccardo, Marcatti, Magda, Rizzo, Nathalie, Bianchi, Vittoria Giulia, Ferla, Valeria, Mercuri, Santo Raffaele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644923/ https://www.ncbi.nlm.nih.gov/pubmed/37850777 http://dx.doi.org/10.23750/abm.v94i5.14279 |
Ejemplares similares
-
A successful case of dupilumab treatment for severe uremic pruritus
por: Silverberg, Jonathan I., et al.
Publicado: (2019) -
Pembrolizumab-induced lichenoid dermatitis treated with dupilumab
por: Park, Jonathan J., et al.
Publicado: (2023) -
Pregabalin and Uremic Pruritus
por: Shubhakaran, Khichar Purnaram
Publicado: (2017) -
Dupilumab for cancer-associated refractory pruritus
por: Talmon, Aviv, et al.
Publicado: (2023) -
De novo case of lichenoid eruption following dupilumab treatment
por: Kim, Tae-Eun, et al.
Publicado: (2021)